{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:47:47Z","timestamp":1778852867467,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000995","name":"ANU Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.vaccine.2019.05.010","type":"journal-article","created":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T16:14:18Z","timestamp":1557591258000},"page":"3451-3456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Routine and pulse vaccination for Lassa virus could reduce high levels of endemic disease: A mathematical modelling study"],"prefix":"10.1016","volume":"37","author":[{"given":"Josephine","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamalini","family":"Lokuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5905-1310","authenticated-orcid":false,"given":"Kathryn","family":"Glass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.05.010_b0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41541-018-0049-5","article-title":"Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development","volume":"3","author":"Hallam","year":"2018","journal-title":"NPJ Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.010_b0010","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","article-title":"Lassa fever: epidemiology, clinical features, and social consequences","volume":"327","author":"Richmond","year":"2003","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.vaccine.2019.05.010_b0015","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/20477724.2017.1369643","article-title":"Understanding the cryptic nature of Lassa fever in West Africa","volume":"111","author":"Gibb","year":"2017","journal-title":"Pathog Glob Health"},{"issue":"10122","key":"10.1016\/j.vaccine.2019.05.010_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)30432-X","article-title":"Lassa fever in Nigeria: the great unknown","volume":"391","author":"Burki","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.05.010_b0025","unstructured":"World Health Organisation: Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens In. http:\/\/www.who.int\/medicines\/ebola-treatment\/WHO-list-of-top-emerging-diseases\/en\/ (accessed 5 November 2018); 2015."},{"issue":"6","key":"10.1016\/j.vaccine.2019.05.010_b0030","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1128\/JCM.00170-17","article-title":"Laboratory diagnosis of Lassa fever","volume":"55","author":"Raabe","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.05.010_b0035","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3201\/eid2204.151814","article-title":"Lassa virus Seroprevalence in Sibirilia Commune, Bougouni district Southern Mali","volume":"22","author":"Sogoba","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.05.010_b0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jcv.2006.08.015","article-title":"Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa","volume":"37","author":"Emmerich","year":"2006","journal-title":"J Clin Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.05.010_b0045","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4269\/ajtmh.16-0675","article-title":"At home with Mastomys and Rattus: human-rodent interactions and potential for primary transmission of Lassa virus in domestic spaces","volume":"96","author":"Bonwitt","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2019.05.010_b0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","article-title":"A prospective study of the epidemiology and ecology of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.05.010_b0055","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4269\/ajtmh.1996.55.661","article-title":"Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea","volume":"55","author":"Ter Meulen","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2019.05.010_b0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamapediatrics.2017.5223","article-title":"What pediatricians should know about Lassa virus","volume":"172","author":"Greenky","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.010_b0065","doi-asserted-by":"crossref","first-page":"e3398","DOI":"10.1371\/journal.pntd.0003398","article-title":"Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of Lassa fever","volume":"9","author":"Lo Iacono","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.05.010_b0070","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cell.2015.07.020","article-title":"Clinical sequencing uncovers origins and evolution of Lassa virus","volume":"162","author":"Andersen","year":"2015","journal-title":"Cell"},{"issue":"10172","key":"10.1016\/j.vaccine.2019.05.010_b0075","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0140-6736(19)30357-5","article-title":"Nigeria's unending war with Lassa fever","volume":"393","author":"Adepoju","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2019.05.010_b0080","doi-asserted-by":"crossref","first-page":"e1003212","DOI":"10.1371\/journal.ppat.1003212","article-title":"Vaccination strategies against highly pathogenic arenaviruses: the next steps toward clinical trials","volume":"9","author":"Olschlager","year":"2013","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.010_b0085","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1038\/s41467-018-06741-w","article-title":"Non-neutralizing antibodies elicited by recombinant Lassa-rabies vaccine are critical for protection against Lassa fever","volume":"9","author":"Abreu-Mota","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2019.05.010_b0090","unstructured":"Centre for Infectious Disease Research and Policy: CEPI announces new collaboration and funding for Lassa vaccine. In. http:\/\/www.cidrap.umn.edu\/news-perspective\/2018\/08\/cepi-announces-new-collaboration-and-funding-lassa-vaccine (accessed 5 November 2018); 2018."},{"key":"10.1016\/j.vaccine.2019.05.010_b0095","doi-asserted-by":"crossref","unstructured":"The Lancet Infectious D: Lassa fever and global health security. The Lancet Infectious Diseases 2018, 18(4).","DOI":"10.1016\/S1473-3099(18)30179-8"},{"issue":"5","key":"10.1016\/j.vaccine.2019.05.010_b0100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.14445\/22315373\/IJMTT-V47P542","article-title":"Mathematical modelling of Lassa fever dynamics with non-drug compliance rate","volume":"47","author":"Faniran","year":"2017","journal-title":"Int J Mathem Trends Technol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.010_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14445\/22315373\/IJMTT-V30P501","article-title":"Basic reproductive number for the spread and control of Lassa fever","volume":"30","author":"Martins","year":"2016","journal-title":"Int J Mathem Trends Technol"},{"key":"10.1016\/j.vaccine.2019.05.010_b0110","first-page":"10","article-title":"A mathematical model for Lassa fever","volume":"1","author":"Okuonghae","year":"2008","journal-title":"J Nigerian Assoc Mathem Phys"},{"issue":"9","key":"10.1016\/j.vaccine.2019.05.010_b0115","doi-asserted-by":"crossref","first-page":"e1839","DOI":"10.1371\/journal.pntd.0001839","article-title":"Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation","volume":"6","author":"Asogun","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.05.010_b0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/rmv.329","article-title":"Towards a human Lassa fever vaccine","volume":"11","author":"Fisher-Hoch","year":"2001","journal-title":"Rev Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.05.010_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/ARJOM\/2018\/37441","article-title":"Sensitivity analysis of the dynamical transmission and control of Lassa fever virus","volume":"9","author":"Akanni","year":"2018","journal-title":"Asian Res J Math"},{"key":"10.1016\/j.vaccine.2019.05.010_b0130","unstructured":"World Health Organisation: Lassa fever - Nigeria. In. http:\/\/www.who.int\/csr\/don\/20-april-2018-lassa-fever-nigeria\/en\/ (accessed 5 November 2018); 2018."},{"key":"10.1016\/j.vaccine.2019.05.010_b0135","unstructured":"World Health Organisation: Lassa fever. In. http:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/lassa-fever (accessed 5 November 2018); 2017."},{"key":"10.1016\/j.vaccine.2019.05.010_b0140","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/0972-9062.211689","article-title":"Prevalence of Lassa virus among rodents trapped in three South-South states of Nigeria","volume":"54","author":"Agbonlahor","year":"2017","journal-title":"J Vector Borne Dis"},{"key":"10.1016\/j.vaccine.2019.05.010_b0145","unstructured":"World Health Organisation: WHO target product profile for Lassa virus vaccine. https:\/\/wwwwhoint\/blueprint\/priority-diseases\/key-action\/LassaVirusVaccineTPPPDF?ua=1 2017."},{"issue":"12","key":"10.1016\/j.vaccine.2019.05.010_b0150","doi-asserted-by":"crossref","first-page":"e0167835","DOI":"10.1371\/journal.pone.0167835","article-title":"Routine vaccination coverage in northern Nigeria: results from 40 district-level cluster surveys, 2014\u20132015","volume":"11","author":"Gunnala","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.05.010_b0155","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1471-2458-8-381","article-title":"Determinants of vaccination coverage in rural Nigeria","volume":"8","author":"Odusanya","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2019.05.010_b0160","unstructured":"Mathworks: Matlab. In. https:\/\/mathworks.com\/products\/matlab.html (accessed 5 November 2018)."},{"issue":"3","key":"10.1016\/j.vaccine.2019.05.010_b0165","article-title":"Mathematical analysis of a Lassa fever model with isolation","volume":"5","author":"Adewale","year":"2016","journal-title":"Asian J Nat Appl Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2019.05.010_b0170","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11538-005-9034-4","article-title":"Mathematical models for hantavirus infection in rodents","volume":"68","author":"Allen","year":"2006","journal-title":"Bull Math Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.05.010_b0175","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0092-8240(03)00013-2","article-title":"Traveling waves of infection in the hantavirus epidemics","volume":"65","author":"Abramson","year":"2003","journal-title":"Bull Math Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.05.010_b0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3934\/mbe.2018004","article-title":"Numerical solution of a spatio-temporal gender-structured model for hantavirus infection in rodents","volume":"15","author":"Burger","year":"2018","journal-title":"Math Biosci Eng"},{"issue":"4 Pt 1","key":"10.1016\/j.vaccine.2019.05.010_b0185","doi-asserted-by":"crossref","first-page":"041908","DOI":"10.1103\/PhysRevE.66.041908","article-title":"Simulations in the mathematical modeling of the spread of the Hantavirus","volume":"66","author":"Aguirre","year":"2002","journal-title":"Phys Rev E Stat Nonlin Soft Matter Phys"},{"key":"10.1016\/j.vaccine.2019.05.010_b0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0025-5564(02)00095-0","article-title":"Stability properties of pulse vaccination strategy in SEIR epidemic model","volume":"179","author":"d'Onofrio","year":"2002","journal-title":"Math Biosci"},{"key":"10.1016\/j.vaccine.2019.05.010_b0195","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0092-8240(98)90005-2","article-title":"Pulse vaccination strategy in the SIR epidemic model","volume":"60","author":"Shulgin","year":"1998","journal-title":"Bull Math Biol"},{"key":"10.1016\/j.vaccine.2019.05.010_b0200","unstructured":"World Health Organisation: Yellow fever - Nigeria. In. https:\/\/www.who.int\/csr\/don\/22-december-2017-yellow-fever-nigeria\/en\/ (accessed 5 November 2018); 2017."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1930622X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1930622X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:32:15Z","timestamp":1759401135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1930622X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":40,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0264410X1930622X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.010","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Routine and pulse vaccination for Lassa virus could reduce high levels of endemic disease: A mathematical modelling study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}